The molecular basis of isoniazid resistance in Mycobacterium tuberculosis

Tubercle and Lung Disease - Tập 79 - Trang 267-271 - 1999
B. Heym1, B. Saint-Joanis2, S.T. Cole2
1Hôpital Ambroise Paré, Boulogne, France
2Unité de Génétique Moléculaire Bactérienne, Institut Pasteur, Paris, France

Tài liệu tham khảo

Meyer, 1912, Über Hydrazinderivate de Pyridincarbonsäuren, Montashefte für Chemie, 33, 393, 10.1007/BF01517946 Fox, 1951, Synthetic Tuberculostatics show promise, Chem Eng News, 29, 3963 Bernstein, 1952, Chemotherapy of Experimental Tuberculosis. V. Isonicotinic Acid Hydrazide (Nydrazid) and Related Compounds, Am Rev Tuberc, 76, 568 Wolinsky, 1979, Nontuberculous Mycobacteria and Associated Diseases, Am Rev Resp Dis, 119, 107 Tsukamura, 1963, Isotopic studies on the Effect of Isoniazid on Protein Synthesis of Mycobacteria, Jap J Tuberc, 11, 14 Youatt, 1969, A review of the Action of Isoniazid, Am Rev Resp Dis, 99, 729 Winder, 1970, Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis, J Gen Microbiol, 63, 41, 10.1099/00221287-63-1-41 Takayama, 1972, Effect of Isoniazid on the in vitro Mycolic Acid Synthesis, Cell Growth and Viability of Mycobacterium tuberculosis, Antimicrob Agents Chemother, 2, 29, 10.1128/AAC.2.1.29 Jackett, 1977, The Relationship between Nicotinamide Adenine Dinucleotide Concentration and Antibacterial Activity of Isoniazid inMycobacterium tuberculosis, Am Rev Resp Dis, 115, 601 Sriprakash, 1970, Isoniazid-resistant Mutants of Mycobacterium tuberculosis H37Rv: Uptake of Isoniazid and the Properties of NADase Inhibitor, J Gen Micorbiol, 60, 125, 10.1099/00221287-60-1-125 Seydel, 1976, Mode of Action and Quantitative Structure-Activity Correlations of Tuberculostatic Drugs of the Isonicotinic Acid Hydrazide Type, J Med Chem, 19, 483, 10.1021/jm00226a007 Youatt, 1969, An Enzyme System of Mycobacterium tuberculosis that reacts specifically with Isoniazid I, Am Rev Respir Dis, 100, 25 Youatt, 1969, An Enzyme System of Mycobacterium tuberculosis that reacts specifically with Isoniazid II, Am Rev Respir Dis, 100, 31 Shoeb, 1985, Evidence for the Generation of Active Oxygen by Isoniazid Treatement of Extracts of Mycobacterium tuberculosis H37Ra, Antimicrob Agents Chemother, 27, 404, 10.1128/AAC.27.3.404 Middlebrook, 1952, Sterilization of Tubercle Bacilli by Isonicotinic Acid Hydrazide and the Incidence of Variants Resistant to the Drug in Vitro, Am Rev Tuberc, 65, 765 Zhang, 1992, The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis, Nature, 358, 591, 10.1038/358591a0 Welinder, 1991, Bacterial Catalase-Peroxidases are Gene Duplicated Members of the Plant Peroxidase Superfamily, Biochem Biophys Act, 1080, 215 Finzel, 1984, Crystal Structure of Yeast Cytochrome C. Peroxidase Refined at 1,7 A Resolution, J Biol Chem, 259, 13027, 10.1016/S0021-9258(18)90651-4 Heym, 1995, Missense Mutations in the Catalase-peroxidase Gene katG are Associated with Isoniazid Resistance inMycobacterium tuberculosis, Mol Microbiol, 15, 235, 10.1111/j.1365-2958.1995.tb02238.x Rouse, 1995, Characterization of the katG and inhA Genes of Isoniazid-Resistant Clinical Isolates ofMycobacterium tuberculosis, Antimicrob Agents Chemother, 39, 2472, 10.1128/AAC.39.11.2472 Musser, 1996, Characterization of the catalase-peroxidase gene (kat G) and inh A locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance, J Infect Dis, 173, 196, 10.1093/infdis/173.1.196 Morris, 1992, The Catalase-Peroxidase of Mycobacterium intracellulare: nucleotide sequence analysis and expression inEscherichia coli, J Gen Microbiol, 138, 2363, 10.1099/00221287-138-11-2363 Heym, 1993, Characterization of the katG Gene Encoding a Catalase-Peroxidase Required for the Isoniazid Susceptibility ofMycobacterium tuberculosis, J Bact, 175, 4255, 10.1128/jb.175.13.4255-4259.1993 Rouse, 1996, Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance, Mol Microbiol, 22, 583, 10.1046/j.1365-2958.1996.00133.x Li, 1998, Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs, J Inf Dis, 177, 1030, 10.1086/515254 Loewen, 1985, Catalases HPI and HPII in Escherichia coli are Induced Independently, Arch Biochem Biophys, 243, 144, 10.1016/0003-9861(85)90782-9 Claiborne, 1979, Purification of the o -Dianisidine Peroxidase from Escherichia coli B, J Biol Chem, 254, 4245, 10.1016/S0021-9258(18)50722-5 Zhang, 1993, Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control, Trends Microbiol, 1, 109, 10.1016/0966-842X(93)90117-A Johnsson, 1994, Mechanistic Studies of the Oxidation of Isoniazid by the Catalase-peroxidase from Mycobacterium tuberculosis, J Am Chem Soc, 116, 7425, 10.1021/ja00095a063 Johnsson, 1995, Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis, J Am Chem Soc, 117, 5009, 10.1021/ja00122a038 Saint-Joanis, 1999, Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis, Biochem J, 338, 753, 10.1042/0264-6021:3380753 Tartaglia, 1989, Identification and Molecular Analysis of oxyR-Regulate Promoters Important for the Bacterial Adaptation to Oxidative Stress, J Mol Biol, 210, 709, 10.1016/0022-2836(89)90104-6 Rosner, 1993, Susceptibilities of oxyR Regulon Mutants of Escherichia coli and Salmonella typhimurium to Isoniazid, Antimicrob Agents Chemother, 37, 2251, 10.1128/AAC.37.10.2251 Sherman, 1995, Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria, Proc Natl Acad Sci USA, 92, 6625, 10.1073/pnas.92.14.6625 Deretic, 1995, Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid, Mol Microbiol, 17, 889, 10.1111/j.1365-2958.1995.mmi_17050889.x Dhandayuthapani, 1996, Oxidative Stress Reponse and Its Role in Sensitivity to Isoniazid in Mycobacteria: Characterization and Inducibility ofahpC by Peroxides in Mycobacterium smegmatis and Lack of Expression in M. aurum and M. tuberculosis, J Bacteriol, 187, 3641, 10.1128/jb.178.12.3641-3649.1996 Deretic, 1996, The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculous drug isoniazid, Nature Biotechnol, 14, 1557, 10.1038/nbt1196-1557 Sherman, 1996, Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis, Science, 272, 1641, 10.1126/science.272.5268.1641 Wilson, 1996, ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex, Mol Microbiol, 19, 1025, 10.1046/j.1365-2958.1996.449980.x Heym, 1997, Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance ofMycobacterium tuberculosis, Infect Immun, 65, 1395, 10.1128/IAI.65.4.1395-1401.1997 Banerjee, 1994, inhA, a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis, Science, 263, 227, 10.1126/science.8284673 Dessen, 1995, Crystal Stucture and Function of the Isoniazid Target of Mycobacterium tuberculosis, Science, 267, 1638, 10.1126/science.7886450 Rist, 1960, L' Activité antituberculeuse de l' Ethionamide, Adv Tuberc Res, 10, 69 Basso, 1998, Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates, J Infect Dis, 178, 769, 10.1086/515362 Mdluli, 1996, Biochemical and genetic data suggest that InhA is not the major target for activated isoniazid in Mycobacterium tuberculosis, J Infect Dis, 174, 1085, 10.1093/infdis/174.5.1085 Mdluli, 1998, Inhibition of a Mycobacterium tuberculosisβ-ketoacyl ACP synthase by isoniazid, Science, 280, 1607, 10.1126/science.280.5369.1607